Biotech Series A Investors & VC Firms
1596 firms in this list, with a median first check of $500K. 341 of them lead rounds. Generated from verified public data and updated continuously.
DNA Capital
São PauloPre-Seed–Late Stage$100K – $5M
15 people
Senovo
MunichSeed–Late Stage$1.1M – $5.4M
6 people
Vesna Advisors
LuxembourgPre-Seed–Series A$200K – $700K
6 people
Amino Collective
BerlinPre-Seed–Series A$216K – $1.6M
8 people
QUBIS
BelfastPre-Seed–Series A$12.7K – $127K
11 people
Xeraya Capital
Kuala LumpurSeed–Growth
20 people
ATOORO FUND
Tel AvivPre-Seed–Series A$500K – $5M
2 people
Kinled Holding
Hong KongSeed–Series A
1 person
Page One Ventures
Silicon ValleyPre-Seed–Series A
4 people
Visionary Ventures
Newport BeachSeries A–Late Stage$5M – $15M
13 people
Foreground Capital
BostonPre-Seed–Series B
9 people
LBBW Venture Capital GmbH
StuttgartSeed–Late Stage$540K – $3.2M
9 people
Marathon Venture Capital
AthensSeed–Series B$250K – $1M
6 people
PsyMed Ventures
BerkeleyPre-Seed–Series A
12 people
Breakthrough Victoria
MelbournePre-Seed–Late Stage
11 people
FemHealth Ventures
Short HillsSeed–Series A
11 people
MBX Capital
ClaymontPre-Seed–Series A$250K – $2.5M
5 people
Shanda Group
Redwood CityPre-Seed–Series A
20 people
Cantos Ventures
San FranciscoPre-Seed–Series B$400K – $1.5M
4 people
FREEFLOW
BerkeleyPre-Seed–Series B
10 people
Okapi Venture Capital
Newport BeachPre-Seed–Series A$750K – $3M
4 people
Partnership Fund for NYC
New York CitySeed–Growth
13 people
Capital Cell
BarcelonaPre-Seed–Growth
Kernel Capital
CorkSeed–Late Stage$1.1M – $5.4M
9 people
Related lists
Series A Investors & VC Firms (7875)Series A Investors & VC Firms in United States (3337)SaaS Series A Investors & VC Firms (2667)AI & Machine Learning Series A Investors & VC Firms (2343)Enterprise Software Series A Investors & VC Firms (2324)Fintech Series A Investors & VC Firms (2239)Healthtech Series A Investors & VC Firms (2210)Series A Investors & VC Firms in Global (2163)Biotech Investors & VC Firms (2107)Biotech Seed Investors & VC Firms (1754)
Data sourced from public filings and firms' own websites — see our methodology.







































































